Real-time SEC alerts Start Free →
Profitelligence
Tilray Brands Inc.
TLRY LOW Impact

Tilray Brands Inc.

Tilray Brands Reports Q2 2025 Financial Results with Revenue Growth and Synergy Plan

| 8-K |Healthcare

Summary

Tilray Brands, Inc. reported its Q2 2025 financial results on January 10, 2025. Net revenue increased by 9% year-over-year to $211 million, with growth across all four business segments. The beverage segment saw a 36% increase in revenue, while the cannabis segment grew by 25%. Gross profit rose 29% to $61 million. The company also announced Project 420, a $25 million synergy plan aimed at optimizing operations and streamlining its product portfolio. Tilray reaffirmed its fiscal year 2025 guidance of net revenues between $950 million and $1 billion.

Profitelligence Profitelligence Alerts

Get alerts for TLRY

Be first to know when Tilray Brands Inc. files with the SEC.

Set Up Alerts →

Filing Categories

General Statement Exhibits Furnished

Exhibits (1)

Advertisement

About Tilray Brands Inc.

Tilray Brands Inc. is a pioneering player in the emerging global cannabis industry. A diversified company, it engages in the research, cultivation, production, and distribution of cannabis and hemp-based products. Tilray's primary function is to develop, produce, and distribute a wide range of medicinal and recreational cannabis products, including dried flower, extracts, and edibles. The company also produces hemp foods and alcoholic beverages. Founded in 2013, Tilray has rapidly gained a significant foothold, serving both medical patients and recreational consumers in multiple countries, including Canada, the United States, and parts of Europe. Tilray Brands Inc. operates within an industry that intersects with pharmaceuticals, consumer goods, and agriculture, heavily impacting sectors such as healthcare, wellness, and food and beverages. Through strategic acquisitions and partnerships, Tilray broadens its product offerings and global market presence. Its emphasis on research and innovation propels its market significance, especially as the demand for alternative wellness products grows. With the cannabis sector continuing to evolve, Tilray is poised as a key contributor to shaping market dynamics, establishing itself as a reputable brand committed to high-quality cannabis and cannabinoid-based products.

Exchange: NASDAQ Industry: Drug Manufacturers - Specialty & Generic Company Website →

Official SEC Documents

TLRY
TLRY Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement